This guidance provides clarification on the recently issued telepractice waiver. Issued March 13, 2020.

Recent guidance on COVID-19 in light of the state of emergency declared in New York State. Issued 3/7/20. Revised 3/11/20

NYS Department of Health has issued additional Medicaid pharmacy guidance regarding the declared Disaster Emergency in the State of New York over COVID-19.

OASAS is waiving certain regulatory requirements for providing telepractice services amidst the COVID-19 outbreak. Complete and return the attached attestation form to begin providing services.

Complete this attestation and return it to [email protected] and [email protected] to begin providing telepractice services amidst the COVID-19 outbreak.

OASAS guidance to Opioid Treatment Programs regarding the coronavirus (COVID-19). Issued March 10, 2020.

NYS Department of Health guidance on and criteria for discontinuation of quarantine of patients with COVID-19. Issued March 9, 2020.

Guidance for group or residential treatment settings on the cleaning and disinfection of frequently touched areas in congregate (non-treatment) settings (e.g., door handles, handrails, shared telephones/computers). 

Guidance for non-hospital-based Inpatient, residential, and outpatient treatment settings where Individuals under the movement restriction for COVID-19 have been admitted or have visited.

Consent for the disclosure of communicable diseases including COVID-19 or Novel Coronavirus to the New York State Department of Health. Updated 3/24/20.